Research Library
CJC-1295 (No DAC) / Ipamorelin research
6 articles to explore, with links to 8 original sources.
About CJC-1295 (No DAC) / Ipamorelin
This blend pairs CJC-1295 No DAC with ipamorelin in the listed Heritage proportions.
Understand the science
What a single-compound time course can show about a proposed pairing
CJC-1295 (No DAC) / Ipamorelin names a modified growth hormone–releasing hormone fragment and ipamorelin, a five-residue ghrelin-receptor agonist. Would the timing of ipamorelin's effect by itself predict the timing of the two-peptide response?
2 sources (1999, 2024)
How researchers defined hormone selectivity for ipamorelin
The label CJC-1295 (No DAC) / Ipamorelin refers to modified growth hormone–releasing factor (1–29) alongside a synthetic five-residue growth hormone secretagogue. In the original ipamorelin research, what did it mean to describe the compound as selective?
3 sources (1998, 2024)
How a bowel-surgery trial differed from a growth hormone experiment
CJC-1295 (No DAC) / Ipamorelin pairs the modified growth hormone–releasing factor known as Mod GRF (1–29) with a five-residue ghrelin-receptor agonist. Why did a clinical trial of ipamorelin focus on when patients could eat after surgery?
3 sources (2014, 2024)
Explore study findings
What was actually paired with ipamorelin in a rat muscle experiment?
CJC-1295 (No DAC) / Ipamorelin combines a name commonly used for Mod GRF (1–29), a modified growth hormone–releasing hormone fragment, with a synthetic five-residue peptide called ipamorelin. Looking at a muscle-force claim starts with identifying which compounds the underlying experiment used.
2 sources (2001, 2024)
What a study would need to attribute a response to either peptide
CJC-1295 (No DAC) / Ipamorelin lists a modified 29-residue growth hormone–releasing hormone analogue and a five-residue agonist of the ghrelin receptor. Would comparing the two together against a control be enough to tell how they interact?
3 sources (1995, 2024)
Check methods and identity
What a combination label can establish about the material inside
CJC-1295 (No DAC) / Ipamorelin names a 29-residue modified growth hormone–releasing factor and a separate five-residue agonist of the ghrelin receptor. Which parts of that identity can a catalog label establish?
3 sources (2024, 2026)
